These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2579436

  • 1. Rationale behind the development of low molecular weight heparin derivatives.
    Hirsh J, Ofosu F, Buchanan M.
    Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Low molecular weight heparins].
    Kher A, Bara L, Samama M.
    Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
    [Abstract] [Full Text] [Related]

  • 5. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1982 Apr 30; 47(2):104-8. PubMed ID: 6179182
    [Abstract] [Full Text] [Related]

  • 6. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE, Kwaan HC, Szczecinski M.
    J Lab Clin Med; 1980 Jun 30; 95(6):783-90. PubMed ID: 6155418
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
    Hirsh J.
    Haemostasis; 1986 Jun 30; 16(2):82-6. PubMed ID: 3710297
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological actions of sulodexide.
    Ofosu FA.
    Semin Thromb Hemost; 1998 Jun 30; 24(2):127-38. PubMed ID: 9579633
    [Abstract] [Full Text] [Related]

  • 10. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 30; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of heparin fractions: some overlooked considerations.
    Fareed J.
    Semin Thromb Hemost; 1985 Apr 30; 11(2):227-36. PubMed ID: 3898374
    [No Abstract] [Full Text] [Related]

  • 14. Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.
    Cipriani TR, Gracher AH, de Souza LM, Fonseca RJ, Belmiro CL, Gorin PA, Sassaki GL, Iacomini M.
    Thromb Haemost; 2009 May 30; 101(5):860-6. PubMed ID: 19404539
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA.
    Nouv Rev Fr Hematol (1978); 1988 May 30; 30(3):155-60. PubMed ID: 2971155
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical efficacy of heparin fractions: issues and answers.
    Messmore HL.
    Crit Rev Clin Lab Sci; 1986 May 30; 23(2):77-94. PubMed ID: 2419035
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments.
    Fareed J, Walenga JM, Williamson K, Emanuele RM, Kumar A, Hoppensteadt DA.
    Semin Thromb Hemost; 1985 Jan 30; 11(1):56-74. PubMed ID: 3883500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.